Compare stocks

Sandoz Group AG operates in the pharmaceutical industry, specializing in the development, manufacturing, and distribution of generic medicines and biosimilars. The company's product portfolio includes a wide range of therapeutic areas, such as antibiotics, oncology, and cardiovascular treatments. Sandoz was founded as part of a broader restructuring that involved the separation from Novartis in 2022, with a focus on enhancing the accessibility of high-quality healthcare solutions. Headquartered in Switzerland, Sandoz has a significant global presence with operations spanning across numerous countries. The company emphasizes cost-effective healthcare, leveraging a substantial manufacturing and research capacity to maintain competitive strengths in the global pharmaceutical market.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.